Lataa...
Targeting immunotherapy for bladder cancer using anti‐CD3× B7‐H3 bispecific antibody
OBJECTIVE: B7‐H3 is attractive for cancer immunotherapy with B7‐H3 overexpressed tumors. To explore whether B7‐H3 is an effective target for patients with bladder cancer, anti‐CD3× anti‐B7‐H3 bispecific antibodies (B7‐H3Bi‐Ab) was armed with activated T cells (ATC) to kill bladder cancer cells. METH...
Tallennettuna:
| Julkaisussa: | Cancer Med |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6198238/ https://ncbi.nlm.nih.gov/pubmed/30253078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1775 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|